Drug intelligence / Profile preview

SynerG

Development stage
Unknown
Lead developer
Cipher Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

SynerG (specifically marketed as SynerG 6.0 by Innocutis, later acquired by Cipher Pharmaceuticals) is a multi-ingredient dietary supplement (MIDS) formulated to support hair, skin, and nail health, particularly in the context of thinning hair. The product is designed to address multiple pathways associated with hair loss, including hormonal balance, oxidative stress, and nutritional deficiencies. Its formulation typically includes a blend of botanical extracts and micronutrients such as biotin, zinc, saw palmetto (Serenoa repens), beta-sitosterol, pygeum africanum, pumpkin seed extract, and green tea extract. Saw palmetto and beta-sitosterol are included for their potential to inhibit 5-alpha-reductase, the enzyme responsible for converting testosterone to dihydrotestosterone (DHT), a primary driver of androgenetic alopecia. The supplement was primarily distributed through physician offices and dermatology clinics as a professional-grade nutraceutical.

Brand names
SynerGSynerG 6.0SynerG6.0SynerG-6.0
Other names
SynerG Multi-Ingredient Dietary Supplement
02

Targets

SRD5A (Steroid 5-alpha-reductase)

Beyond the preview

Go deeper on SynerG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynerG.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call